{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:47:08Z","timestamp":1790286428150,"version":"4.1.0"},"reference-count":109,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The increasing prevalence of food allergies worldwide and the subsequent life-threatening anaphylactic reactions often have sparse treatment options, providing only symptomatic relief. Great strides have been made in research and in clinics in recent years to offer novel therapies for the treatment of allergic disorders. However, current allergen immunotherapy has its own shortcomings in terms of long-term efficacy and safety, due to the local side effects and the possibility of anaphylaxis. Allergen-specific immunotherapy is an established therapy in treating allergic asthma, allergic rhinitis, and allergic conjunctivitis. It acts through the downregulation of T cell, and IgE-mediated reactions, as well as desensitization, a process of food tolerance without any allergic events. This would result in a protective reaction that lasts for approximately 3 years, even after the withdrawal of therapy. Furthermore, allergen-specific immunotherapy also exploits several routes such as oral, sublingual, and epicutaneous immunotherapy. As the safety and efficacy of allergen immunotherapy are still under research, the exploration of newer routes such as intra-lymphatic immunotherapy would address unfulfilled needs. In addition, the existence of nanoparticles can be exploited immensely in allergen immunotherapy, which would lead to safer and efficacious therapy. This manuscript highlights a novel drug delivery method for allergen-specific immunotherapy that involves the administration of specific allergens to the patients in gradual increasing doses, to induce desensitization and tolerance, as well as emphasizing different routes of administration, mechanism, and the application of nanoparticles in allergen-specific immunotherapy.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1229667","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T12:16:46Z","timestamp":1694175406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Modulation of immune response by nanoparticle-based immunotherapy against food allergens"],"prefix":"10.3389","volume":"14","author":[{"given":"Sivadas Swathi","family":"Krishna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Ayesha","family":"Farhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardra","family":"T.P.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalam M.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidya","family":"Viswanad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Hassan","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyauddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.33590\/emj\/10310420","article-title":"Allergen-specific immunotherapy for im-munoglobulin E-mediated food allergy","volume":"4","author":"Hiera","year":"2019","journal-title":"Eur Med J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.26452\/ijrps.v11i2.2250","article-title":"Allergen Immunotherapy: Tactic in manipulating food allergen induced anaphylaxis","volume":"11","author":"Saritha","year":"2020","journal-title":"Int J Res Pharm Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40413-015-0063-2","article-title":"Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens","volume":"8","author":"Akdis","year":"2015","journal-title":"World Allergy Organ J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/bios10020010","article-title":"Cutting-edge advances in electrochemical affinity biosensing at different molecular level of emerging food allergens and adulterants","volume":"10","author":"Campuzano","year":"2020","journal-title":"Biosensors (Basel)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2016.111","article-title":"Food allergy: immune mechanisms, diagnosis and immunotherapy","volume":"16","author":"Yu","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/all.13319","article-title":"EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy","volume":"73","author":"Pajno","year":"2018","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/bios10120194","article-title":"A systematic review of food allergy: Nanobiosensor and food allergen detection","volume":"10","author":"Aquino","year":"2020","journal-title":"Biosensors (Basel)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/s18041087","article-title":"Biosensing based on nanoparticles for food allergens detection","volume":"18","author":"G\u00f3mez-Arribas","year":"2018","journal-title":"Sensors (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2174\/1573413718666220426101432","article-title":"Nanotechnology as a promising approach for detection, diagnosis and treatment of food allergens","volume":"19","author":"Rai","year":"2023","journal-title":"Curr Nanosci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.05.017","article-title":"Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells","volume":"41","author":"Burton","year":"2014","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2249.2008.03713.x","article-title":"Allergy and the gastrointestinal system","volume":"153","author":"Vighi","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8710-3","article-title":"IgE-mediated food allergy","volume":"57","author":"Anvari","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-2-2-78","article-title":"Nonimmunoglobulin E-mediated immune reactions to foods","volume":"2","author":"Spergel","year":"2006","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/nu13010226","article-title":"Non\u2013IgE, or mixed IgE\/non\u2013IgE-mediated gastrointestinal food allergies in the first years of life: Old and new tools for diagnosis","volume":"13","author":"Calvani","year":"2021","journal-title":"Nutrients"},{"key":"B15","article-title":"Food allergy, classification, symptoms, diagnosis and prevention-review","volume":"4","author":"Al-Farga","year":"2017","journal-title":"Int J Agric Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040835","article-title":"Non-IgE\/mixed food allergies and functional gastrointestinal disorder: A common thread between childhood and adulthood","volume":"14","author":"Caio","year":"2022","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/1573396315666191031103714","article-title":"Non-IgE mediated food allergy","volume":"16","author":"Cianferoni","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2013.07.011","article-title":"Oral and sublingual immunotherapy for food allergy: current progress and future directions","volume":"25","author":"Moran","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.03.015","article-title":"Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s","volume":"147","author":"Bartemes","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/all.14776","article-title":"Innate lymphoid cells: The missing part of a puzzle in food allergy","volume":"76","author":"Sahiner","year":"2021","journal-title":"Allergy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41590-020-0745-y","article-title":"ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung","volume":"21","author":"Schuijs","year":"2020","journal-title":"Nat Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211053156","article-title":"Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target","volume":"50","author":"Jin","year":"2022","journal-title":"J Int Med Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/jci124606","article-title":"Epithelial cell\u2013derived cytokines: more than just signaling the alarm","volume":"129","author":"Roan","year":"2019","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/foods10051037","article-title":"New insights in therapy for food allergy","volume":"10","author":"Mayorga","year":"2021","journal-title":"Foods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000515292","article-title":"Fighting food allergy by inducing oral tolerance: Facts and fiction","volume":"182","author":"Yang","year":"2021","journal-title":"Int Arch Allergy Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01499","article-title":"M cells: Intelligent engineering of mucosal immune surveillance","volume":"10","author":"Dillon","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02883","article-title":"Intestinal dendritic cells in health and gut inflammation","volume":"9","author":"Stagg","year":"2018","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/pai.13127","article-title":"Epicutaneous sensitization to food allergens in atopic dermatitis: What do we know","volume":"31","author":"Tham","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.11.005","article-title":"Mechanisms of food allergy","volume":"141","author":"Sampson","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1398-9995.2011.02560.x","article-title":"Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?: Epicutaneous allergen immunotherapy","volume":"66","author":"Senti","year":"2011","journal-title":"Allergy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.1098","article-title":"Future therapies for food allergies","volume":"127","author":"Nowak-W\u0119grzyn","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.12.004","article-title":"Immunotherapy for food allergy: Are we there yet","volume":"5","author":"Gernez","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2015.03.047","article-title":"Amidase, a cell wall hydrolase, elicits protective immunity against Staphylococcus aureus and S. epidermidis","volume":"77","author":"Nair","year":"2015","journal-title":"Int J Biol Macromol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/474605","article-title":"Nanoparticulate adjuvants and delivery systems for allergen immunotherapy","volume":"2012","author":"De Souza Rebou\u00e7as","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55100684","article-title":"Oral Immunotherapy (OIT): A personalized medicine","volume":"55","author":"Mori","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"B38","volume-title":"Middleton\u2019s allergy : principles and practice","author":"Burks;","year":"2020"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.01.012","article-title":"IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens","volume":"135","author":"Santos","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603050","article-title":"IgE and IgG antibodies as regulators of mast cell and basophil functions in food allergy","volume":"11","author":"Kanagaratham","year":"2020","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.01.001","article-title":"Food allergen immunotherapy: Current status and prospects for the future","volume":"137","author":"Wood","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B42","article-title":"An overview on allergen immunotherapy for allergic asthma with emphasis on subcuta-neous and sublingual immunotherapy | Annals of the rOmanian society for cell biology","volume":"25","author":"Pullanikkad","year":"2021","journal-title":"Overview Allergen Immunotherapy Allergic Asthma Emphasis Subcuta-neous Sublingual Immunotherapy | Ann ROmanian Soc Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5604\/12321966.1196851","article-title":"Sublingual immunotherapy (SLIT) \u2013 indications, mechanism, and efficacy Position paper prepared by the Section of Immunotherapy, Polish Society of Allergy","volume":"23","author":"Jutel","year":"2015","journal-title":"Ann Agric Environ Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jaip.2016.07.020","article-title":"Enhancing allergen-presentation platforms for sublingual immunotherapy","volume":"5","author":"Moingeon","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.12.031","article-title":"Formulation and in-vitro characterization of fast-disintegrating herbal extract sublingual immunotherapy tablet for peanut-induced allergic asthma","volume":"29","author":"Aswathy","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/foods10050970","article-title":"Oral mucosa as a potential site for diagnosis and treatment of allergic and autoimmune diseases","volume":"10","author":"Gomez-Casado","year":"2021","journal-title":"Foods"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12901","article-title":"The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions","volume":"47","author":"Gomez","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ. J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.01.007","article-title":"Immunotherapy: what lies beyond","volume":"133","author":"Casale","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/aci.0b013e328364f4df","article-title":"New approaches to transcutaneous immunotherapy: Targeting dendritic cells with novel allergen conjugates","volume":"13","author":"Weiss","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12869","article-title":"Safety and efficacy of epicutaneous immunotherapy for food allergy","volume":"29","author":"Wang","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4168\/aair.2018.10.3.189","article-title":"Nowak-wegrzyn, A. Allergen-specific immunotherapies for food allergy","volume":"10","author":"Feuille","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3345\/kjp.2016.59.2.47","article-title":"A practical view of immunotherapy for food allergy","volume":"59","author":"Song","year":"2016","journal-title":"Korean J Pediatr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.01.036","article-title":"Allergen immunotherapy: Where is it now","volume":"119","author":"Nelson","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum Vaccin. Immunother"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1348447","article-title":"and irache, J Adjuvants for allergy immunotherapeutics","volume":"13","author":"Gamazo","year":"2017","journal-title":"M.Hum Vaccin. Immunother"},{"key":"B57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40064-015-0972-0","article-title":"The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm","volume":"4","author":"Ghimire","year":"2015","journal-title":"Springerplus"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020237","article-title":"Nanotechnology-based vaccines for allergen-specific immunotherapy: Potentials and challenges of conventional and novel adjuvants under research","volume":"8","author":"Johnson","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/1744666x.2017.1292133","article-title":"Clinical use of adjuvants in allergen-immunotherapy","volume":"13","author":"Klimek","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12879-017-2329-5","article-title":"Comparison of a novel microcrystalline tyrosine adjuvant with aluminium hydroxide for enhancing vaccination against seasonal influenza","volume":"17","author":"Heath","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40425-019-0587-z","article-title":"Vaccination with nanoparticles combined with micro-adjuvants protects against cancer","volume":"7","author":"Mohsen","year":"2019","journal-title":"J Immunother. Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater. Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.06.001","article-title":"Nanomedicine for prostate cancer using nanoemulsion: A review","volume":"260","author":"Sasikumar","year":"2017","journal-title":"J Control. Release"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.788128","article-title":"An insight to brain targeting utilizing polymeric nanoparticles: Effective treatment modalities for neurological disorders and brain tumor","volume":"10","author":"Annu","year":"2022","journal-title":"Front Bioeng. Biotechnol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060866","article-title":"Formulations based on drug loaded aptamer-conjugated liposomes as a viable strategy for the topical treatment of basal cell carcinoma-in vitro tests","volume":"13","author":"Cadinoiu","year":"2021","journal-title":"Pharmaceutics"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.nanoso.2019.100397","article-title":"Recent developments in functionalized polymer nanoparticles for efficient drug delivery system","volume":"20","author":"Sur","year":"2019","journal-title":"Nano-struct nano-objects"},{"key":"B67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/B978-0-323-50922-0.00004-3","article-title":"Pharmaceutical perspectives of selection criteria and toxicity profiling of nanotheranostic agents","volume-title":"Drug delivery nanosystems for biomedical applications","author":"Radhakrishnan","year":"2018"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S134630","article-title":"Nanoparticle-allergen complexes for allergen immunotherapy","volume":"12","author":"Felice","year":"2017","journal-title":"Int J Nanomed"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/all.13199","article-title":"Recent advances in the use of nanoparticles for allergen-specific immunotherapy","volume":"72","author":"Pohlit","year":"2017","journal-title":"Allergy"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.04.015","article-title":"Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system","volume":"278","author":"Huang","year":"2018","journal-title":"J Control Release"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.03.003","article-title":"Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB\/c mice","volume":"85","author":"Pali-Sch\u00f6ll","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01604","article-title":"Poly-\u03b3-glutamic acid complexed with alum induces cross-protective immunity of pandemic H1N1 vaccine","volume":"10","author":"Nguyen","year":"2019","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666171201114353","article-title":"New treatments for allergy: Advances in peptide immunotherapy","volume":"25","author":"Calzada","year":"2018","journal-title":"Curr Med Chem"},{"key":"B74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.iac.2019.09.010","article-title":"Highlights of novel vaccination strategies in allergen immunotherapy","volume":"40","author":"Koml\u00f3si","year":"2020","journal-title":"Immunol Allergy Clin North Am"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2174\/1389203720666190718152534","article-title":"Perspectives in allergen-specific Immunotherapy: Molecular evolution of peptide, and protein-based strategies","volume":"21","author":"Jacquet","year":"2020","journal-title":"Curr Protein Pept Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/pharmaceutics13071007","article-title":"Peptide allergen immunotherapy: A new perspective in Olive-pollen allergy","volume":"13","author":"Calzada","year":"2021","journal-title":"Pharmaceutics"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00601.x","article-title":"Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25+ T cells: a double-blind placebo-controlled study","volume":"59","author":"Smith","year":"2004","journal-title":"Allergy"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082901","article-title":"Peptide immunotherapy in allergic asthma generates IL-10\u2013dependent immunological tolerance associated with linked epitope suppression","volume":"206","author":"Campbell","year":"2009","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02143.x","article-title":"Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects","volume":"35","author":"Alexander","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201402-090AW","article-title":"Mechanisms of peptide immunotherapy in allergic airways disease","author":"Larch\u00e9","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.08.003","article-title":"Preparation and characterization of biodegradable nanoparticles based on poly(gamma-glutamic acid) with l-phenylalanine as a protein carrier","volume":"108","author":"Akagi","year":"2005","journal-title":"J Control Release"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.05.004","article-title":"Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy","volume":"28","author":"Broos","year":"2010","journal-title":"Vaccine"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.3390\/NANO11112966","article-title":"Biocompati-bility computation of muscle cells on polyhedral oligomeric silsesquioxane-grafted polyurethane na-nomatrix","volume":"11","author":"Amna","year":"2021","journal-title":"Nanomater"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.05.065","article-title":"Modulation of allergic responses in mice by using biodegradable poly(lactide-co-glycolide) microspheres","volume":"114","author":"Jilek","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejpb.2018.02.011","article-title":"Poly(anhydride) nanoparticles containing cashew nut proteins can induce a strong Th1 and Treg immune response after oral administration","volume":"127","author":"Pereira","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2013.05.011","article-title":"DermAll nanomedicine for allergen-specific immunotherapy","volume":"9","author":"Garaczi","year":"2013","journal-title":"Nanomedicine"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-012-4666-z","article-title":"Classy non-wovens based on animate L. gasseri-inanimate poly(vinyl alcohol): upstream application in food engineering","volume":"97","author":"Amna","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e0150463","DOI":"10.1371\/journal.pone.0150463","article-title":"Mouse model of cat allergic rhinitis and intranasal liposome-adjuvanted refined fel d 1 vaccine","volume":"11","author":"Tasaniyananda","year":"2016","journal-title":"PloS One"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s137033","article-title":"Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen","volume":"12","author":"Aliu","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S137033","article-title":"Enhanced efficacy of sublingual immunotherapy by lipo-some-mediated delivery of allergen","volume":"12","author":"Rask","year":"2017","journal-title":"Int J Nanomed"},{"key":"B92","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog Polym Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00441","article-title":"Polymerization of ethylene oxide, propylene oxide, and other alkylene oxides: Synthesis, novel polymer architectures, and bioconjugation","volume":"116","author":"Herzberger","year":"2016","journal-title":"Chem Rev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.5b00458","article-title":"Biodegradable pH-sensitive poly(ethylene glycol) nanocarriers for allergen encapsulation and controlled release","volume":"16","author":"Pohlit","year":"2015","journal-title":"Biomacromolecules"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2013.09.005","article-title":"When carbon nanotubes encounter the immune system: desirable and undesirable effects","volume":"65","author":"Dumortier","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"B96","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1038\/s41598-019-40114-7","article-title":"Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci Rep"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-013-1116-3","article-title":"Exposure to multi-walled carbon nanotubes results in aggravation of airway inflammation and remodeling and in increased production of epithelium-derived innate cytokines in a mouse model of asthma","volume":"88","author":"Ronzani","year":"2014","journal-title":"Arch Toxicol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.665","article-title":"Fullerene nanomaterials inhibit the allergic response","volume":"179","author":"Ryan","year":"2007","journal-title":"J Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jaci.2012.04.023","article-title":"Epoxyeicosatrienoic acids are involved in the C70 fullerene derivative\u2013induced control of allergic asthma","volume":"130","author":"Norton","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-016-0159-z","article-title":"Anti-inflammatory effect of fullerene C60 in a mice model of atopic dermatitis","volume":"14","author":"Shershakova","year":"2016","journal-title":"J Nanobiotechnology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150414145323","article-title":"Metal based frameworks for drug delivery systems","volume":"15","author":"Popescu","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2015.2024","article-title":"Local administration of gold nanoparticles prevents pivotal pathological changes in Murine models of atopic asthma","volume":"11","author":"Barreto","year":"2015","journal-title":"J Biomed Nanotechnol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00359-14","article-title":"Immunogenicity of peanut proteins containing poly(anhydride) nanoparticles","volume":"21","author":"De S Rebou\u00e7as","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201100386","article-title":"Recognition and uptake of free and nanoparticle-bound betalactoglobulin , a food allergen , by human monocytes","volume":"55","author":"Marengo","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaci.2016.01.047","article-title":"Investigation of peanut oral immunotherapy with CpG\/peanut nanoparticles in a murine model of peanut allergy","volume":"138","author":"Srivastava","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/7385","article-title":"Oral gene delivery with chitosan\u2013DNA nanoparticles generates immunologic protection in a murine model of peanut allergy","volume":"5","author":"Roy","year":"1999","journal-title":"Nat Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2021.101370","article-title":"Use of a liver-targeting nanoparticle platform to intervene in peanut-induced anaphylaxis through delivery of an Ara h2 T-cell epitope","volume":"42","author":"Liu","year":"2022","journal-title":"Nano Today"},{"key":"B108","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.fbio.2023.102353","article-title":"Gold nanoparticle-based lateral flow immunoassay for the rapid and on-site detection of wheat allergen in milk","volume":"51","author":"Hu","year":"2023","journal-title":"Food Bioscience"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1053107","article-title":"Oral pretreatment with \u03b2-lactoglobulin derived peptide and CpG co-encapsulated in PLGA nanoparticles prior to sensitizations attenuates cow\u2019s milk allergy development in mice","volume":"13","author":"Liu","year":"2023","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.3389\/fimmu.2023.1332906","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1229667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T08:38:40Z","timestamp":1701851920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1229667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,8]]},"references-count":109,"alternative-id":["10.3389\/fimmu.2023.1229667"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1229667","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2023.1332906","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,8]]},"article-number":"1229667"}}